丹麦制药巨头诺和诺德最近发布了2025上半年财报，“减肥神药”司美格鲁肽三款剂型实现1127.56亿丹麦克朗（约167亿美元）的销售额，合计贡献近73%的营收，这被视作司美格鲁肽正式接过K药全球“药王”权杖的关键一刻。

Trump administration demands lower U.S. prices on drugs like Mounjaro, forcing the pharmaceutical company to raise them in ...

Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Doctors report insurance cuts are forcing many U.S. patients on Wegovy and Zepbound to pay high out-of-pocket costs.

Through a trust, Dudum sold about $33.4 million worth of his company’s stock on Thursday, according to a filing with the ...

This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 3.6% in the afternoon session after the ...

Hims & Hers Health ( NYSE: HIMS) shares traded lower for the second straight session on Tuesday after the telehealth firm’s ...

在此前不久公布的财报中，诺和诺德披露2025年上半年司美格鲁肽的合计销售额约为166.32亿美元。目前司美格鲁肽一共被开发成了三款产品：即Ozempic（降糖注射剂）、Rybelsus（降糖口服剂）和Wegovy（减重注射剂），今年上半年，这三款产品 ...

If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...

'America's housing market is shaking and it's being felt right down to its home-building foundations.